About/Charitable Organization/Lawrence/Curing Type 1 Diabetes
All you need is here http://nomoresuffering.jdrftype1.com
Each year, the second full week of April is dedicated to the men and women who serve as public safety telecommunicators. This year, Michael Clark was recognized as the Dispatcher of the Year during the week-long recognition of telecommunicators. Mayor Steve Collier and LPD Chief David Hofmann presented Clark with the award. Communications Director LiAnn Wolfe said it is Clark’s second time to receive the award for outstanding service.
The annual recognition began when It was first conceived by Patricia Anderson of the Contra Costa County (Calif.) Sheriff’s Office in 1981 and was observed only at that agency for three years. Members of the Virginia and North Carolina chapters of the Association of Public-Safety Communications Officials (APCO) became involved in the mid-1980’s. See full list of Video Credits http://broadcaster.beazil.net/public/credits/youtube/videos/44095 The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services Type 1 diabetes (Juvenile Diabetes) is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. Only 5% of people with diabetes have this form of the disease.
In type 1 diabetes, the body does not produce insulin. The body breaks down the sugars and starches you eat into a simple sugar called glucose, which it uses for energy. Insulin is a hormone that the body needs to get glucose from the bloodstream into the cells of the body. With the help of insulin therapy and other treatments, even young children can learn to manage their condition and live long, healthy lives.
18.2 million people in the United States (6.3 percent of the population) have been diagnosed with diabetes. 5 to 10 percent of all people with diabetes have Type 1 Diabetes (T1D). JDRF is the world’s leading charitable funder of type 1 diabetes research and raise money to drive world class research. We aim to find new ways to treat type 1 diabetes and its complications, prevent type 1 from developing and find the cure for people who already have the condition. JDRF’s research mission is to discover, develop, and deliver advances that cure, better treat, and prevent T1D. As the global leader in the fight against T1D, JDRF’s research programs are comprehensive – addressing the hopes and dreams of every person with T1D for the best quality of life and a cure for this disease. Millions of people around the world live with type 1 diabetes (T1D), a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent it, and at present, no cure. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
Visit our blog page http://jdrf.org/blog/
Show us if you like our Google Plus account https://plus.google.com/110620633690555176280/
Join us at our YouTube channel https://www.youtube.com/user/jdrfonline
Learn more at https://www.facebook.com/myJDRF
Welcome to https://twitter.com/JDRFTypeOne
Join us at our Linkedin account https://www.linkedin.com/company/jdrf
Check our Instagram account https://www.instagram.com/jdrfadvocacy/
Join us at our Pinterest account https://www.pinterest.com/jdrfadvocacy/
To sum up, the major issues that were mentioned are:
Lawrence,transplantation insulin-secreting cells,Living with Type 1,fasting plasma glucose value,Bag of Hope,cure therapies,take action,PIs,mean glucose,Weight Loss Support,VADT Trial,Somogyi effect,Apidra,oral hypoglycemic agents,autoimmune therapies,very-long-acting insulin,fundraising,Cystic fibrosis–related diabetes,NRTIs,methods to cure T1D,Diabetes Complications,Levemir,noninsulin monotherapy,Beta Cell Health and Survival,insulin glulisine,Top Research Highlights,Young Leadership Committee,OGTT,CDE,Betta Cells,Research Grants,Clinicians,Government Advocacy,U.S.A,Long.